Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14450-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14450-1-AP, RRID:AB_2208263
- Product name
- TSHR antibody
- Antibody type
- Polyclonal
- Description
- TSHR antibody (Cat. #14450-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references TSH Combined with TSHR Aggravates Diabetic Peripheral Neuropathy by Promoting Oxidative Stress and Apoptosis in Schwann Cells.
Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening.
Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAFV600E by synergistically decreasing global trimethylation of H3K27.
Long Non-coding Antisense RNA TNRC6C-AS1 Is Activated in Papillary Thyroid Cancer and Promotes Cancer Progression by Suppressing TNRC6C Expression.
A somatic mutation of RasGRP3 decreases Na+/I- symporter expression in metastases of radioactive iodine-refractory thyroid cancer by stimulating the Akt signaling pathway.
Acute exposure of zebrafish embryo (Danio rerio) to flutolanil reveals its developmental mechanism of toxicity via disrupting the thyroid system and metabolism.
Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves' disease.
Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer.
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E.
Dominant negative effect of mutated thyroid stimulating hormone receptor (P556L) causes hypothyroidism in C.RF-Tshr(hyt/wild) mice.
Fan J, Pan Q, Gao Q, Li W, Xiao F, Guo L
Oxidative medicine and cellular longevity 2021;2021:2482453
Oxidative medicine and cellular longevity 2021;2021:2482453
Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening.
Sondorp LHJ, Ogundipe VML, Groen AH, Kelder W, Kemper A, Links TP, Coppes RP, Kruijff S
Cancers 2020 Oct 31;12(11)
Cancers 2020 Oct 31;12(11)
Combined tazemetostat and MAPKi enhances differentiation of papillary thyroid cancer cells harbouring BRAFV600E by synergistically decreasing global trimethylation of H3K27.
Fu H, Cheng L, Sa R, Jin Y, Chen L
Journal of cellular and molecular medicine 2020 Mar;24(6):3336-3345
Journal of cellular and molecular medicine 2020 Mar;24(6):3336-3345
Long Non-coding Antisense RNA TNRC6C-AS1 Is Activated in Papillary Thyroid Cancer and Promotes Cancer Progression by Suppressing TNRC6C Expression.
Muhanhali D, Zhai T, Jiang J, Ai Z, Zhu W, Ling Y
Frontiers in endocrinology 2018;9:360
Frontiers in endocrinology 2018;9:360
A somatic mutation of RasGRP3 decreases Na+/I- symporter expression in metastases of radioactive iodine-refractory thyroid cancer by stimulating the Akt signaling pathway.
Song J, Qiu W, Deng X, Qiu Z, Fan Y, Yang Z
American journal of cancer research 2018;8(9):1847-1855
American journal of cancer research 2018;8(9):1847-1855
Acute exposure of zebrafish embryo (Danio rerio) to flutolanil reveals its developmental mechanism of toxicity via disrupting the thyroid system and metabolism.
Teng M, Zhu W, Wang D, Yan J, Qi S, Song M, Wang C
Environmental pollution (Barking, Essex : 1987) 2018 Nov;242(Pt B):1157-1165
Environmental pollution (Barking, Essex : 1987) 2018 Nov;242(Pt B):1157-1165
Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves' disease.
Chen X, Huang F, Qi Y, Zhou M, Yin Q, Peng Y, Zhou Y, Ning G, Wang S
Journal of translational medicine 2018 Jul 5;16(1):188
Journal of translational medicine 2018 Jul 5;16(1):188
Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer.
Wei WJ, Sun ZK, Shen CT, Song HJ, Zhang XY, Qiu ZL, Luo QY
Theranostics 2017;7(4):987-1001
Theranostics 2017;7(4):987-1001
HER inhibitor promotes BRAF/MEK inhibitor-induced redifferentiation in papillary thyroid cancer harboring BRAFV600E.
Cheng L, Jin Y, Liu M, Ruan M, Chen L
Oncotarget 2017 Mar 21;8(12):19843-19854
Oncotarget 2017 Mar 21;8(12):19843-19854
Dominant negative effect of mutated thyroid stimulating hormone receptor (P556L) causes hypothyroidism in C.RF-Tshr(hyt/wild) mice.
Endo T, Kobayashi T
PloS one 2012;7(8):e42358
PloS one 2012;7(8):e42358
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TSHR antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human TSHR. This antibody recognizes human, mouse antigen. The TSHR antibody has been validated for the following applications: ELISA, WB analysis.
